tiprankstipranks
Trending News
More News >
Enhabit, Inc (EHAB)
:EHAB
US Market
Advertisement

Enhabit, Inc (EHAB) Earnings Dates, Call Summary & Reports

Compare
39 Followers

Earnings Data

Report Date
Mar 11, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.16
Last Year’s EPS
0.04
Same Quarter Last Year
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 04, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
Enhabit delivered strong financial and operational performance, including significant growth in admissions and hospice profitability, and successfully renegotiated payer contracts. However, challenges remain in Home Health revenue stagnation and potential future impacts from CMS pricing changes.
Company Guidance
During the third quarter of 2025 earnings call for Enhabit Inc., several key metrics were highlighted, reflecting the company's strong performance and strategic initiatives. Home health total admissions increased by 3.6% year-over-year, with a 3.7% rise in census, and normalized admission growth of 4.3% when accounting for closed branches. Non-Medicare admissions surged by 10.4%, contributing to a 2.8% increase in non-Medicare revenue per visit year-over-year. The company successfully renegotiated a national payer contract, achieving a low double-digit increase in per visit rates effective August 15, 2025, and admissions with this payer rose to 120% of the weekly average by late September. Enhabit reported seven consecutive quarters of sequential census growth in its hospice segment, with a 12.6% increase in census and a 1.4% year-over-year rise in total admissions. The company added 11% more direct sales team members to broaden its referral sources and opened seven de novo locations year-to-date, aiming for a total of ten by the end of 2025. Financially, Enhabit reported consolidated net revenue of $263.6 million, a 3.9% increase from the prior year, with adjusted EBITDA of $27 million, reflecting a 10.2% year-over-year growth and a 50 basis point improvement in EBITDA margin. The company also reduced its net debt to adjusted EBITDA leverage ratio to 3.9x, down from 5.4x in Q4 2023, leading to a $19 million reduction in annualized cash interest expense. Enhabit updated its full-year guidance, projecting revenues between $1.058 billion and $1.063 billion, with adjusted EBITDA expected to range from $106 million to $109 million, and adjusted free cash flow guidance increased to between $53 million and $61 million.
Recognition for Workplace Excellence
Enhabit has been named as one of Fortune's Best Places to Work in health care, highlighting a culture of excellence and strong leadership.
Strong Home Health Admission Growth
Home health total admissions were up 3.6% year-over-year, with a 4.3% increase when normalized for closed branches.
Successful Payer Renegotiations
Renegotiations with a national payer led to a low double-digit increase in per visit rates effective August 15, 2025, with admissions reaching 120% of the weekly average.
Record Hospice Performance
The Hospice segment delivered record revenues and profitability with a 70% year-over-year segment adjusted EBITDA growth and 20% revenue growth.
Improved Financial Health
Net debt to adjusted EBITDA leverage reduced to 3.9x from 5.4x in Q4 2023, lowering annualized cash interest expense by approximately $19 million.
Increase in Full Year Guidance
Full year adjusted EBITDA guidance increased to a range of $106 million to $109 million, and adjusted free cash flow guidance increased to $53 million to $61 million.

Enhabit, Inc (EHAB) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

EHAB Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 11, 2026
2025 (Q4)
0.15 / -
0.04
Nov 04, 2025
2025 (Q3)
0.12 / 0.17
0.03466.67% (+0.14)
Aug 06, 2025
2025 (Q2)
0.10 / 0.13
0.0785.71% (+0.06)
May 07, 2025
2025 (Q1)
0.06 / 0.10
0.0742.86% (+0.03)
Mar 05, 2025
2024 (Q4)
0.05 / 0.04
0.06-33.33% (-0.02)
Nov 06, 2024
2024 (Q3)
0.04 / 0.03
0.030.00% (0.00)
Aug 06, 2024
2024 (Q2)
0.06 / 0.07
0.0475.00% (+0.03)
May 08, 2024
2024 (Q1)
0.05 / 0.07
0.09-22.22% (-0.02)
Mar 06, 2024
2023 (Q4)
0.03 / 0.06
0.32-81.25% (-0.26)
Nov 07, 2023
2023 (Q3)
0.06 / 0.03
0.19-84.21% (-0.16)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

EHAB Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 04, 2025
$8.15$8.21+0.74%
Aug 06, 2025
$6.77$7.80+15.21%
May 07, 2025
$8.20$9.69+18.17%
Mar 05, 2025
$8.54$8.02-6.09%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Enhabit, Inc (EHAB) report earnings?
Enhabit, Inc (EHAB) is schdueled to report earning on Mar 11, 2026, After Close (Confirmed).
    What is Enhabit, Inc (EHAB) earnings time?
    Enhabit, Inc (EHAB) earnings time is at Mar 11, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is EHAB EPS forecast?
          EHAB EPS forecast for the fiscal quarter 2025 (Q4) is 0.16.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis